Home DKmedtech Showcases Directional Scoring Balloon Systems at Three Major International Conferences in 2025

DKmedtech Showcases Directional Scoring Balloon Systems at Three Major International Conferences in 2025

Sep 19, 2025 18:37 CST Updated 18:37
DK Medtech

Vascular Interventional Balloon Product Developer


MYLIVE 2025

DKmedtech

MYLIVE (Malaysia Cardiovascular Intervention Symposium) 2025 Grandly Opens in Kuala Lumpur from September 11 to 13. As the annual core event in Malaysia’s interventional healthcare field, this conference has been meticulously prepared by the Malaysian Interventional Cardiovascular Society (ICSM) and strongly supported by the National Heart Association of Malaysia (NHAM). It aims to establish a professional exchange platform for the global cardiovascular intervention community — bringing together cardiologists, interventional treatment physicians, and industry representatives from around the world to explore cutting-edge advancements and promote clinical progress.

Image


Notably, this MYLIVE is alsoDK Score® Coronary Scoring Balloon Makes Its "Official Debut" in the Malaysian Market—— The meeting not only announced the official launch of the product but also highlighted its technical advantages through a "clinical practice + expert interpretation" dual format. During the conference, DK Medtech collaborated with Emedhealth to conduct a live broadcast of a proximal to mid right coronary artery (RCA) surgery at Serdang Hospital in Malaysia. The procedure was jointly performed by Dr. Rustem Dautov from The Prince Charles Hospital in Australia and Dr. Liew Houng Bang from Elizabeth II Hospital in Malaysia. Throughout the surgery, the DK Score® Coronary Scoring Balloon was used for lesion vessel preparation, vividly demonstrating the product's clinical value in the vascular preparation phase.

Image


In addition, in Dr. Rustem's专题分享 titled "New Devices in CTO PCI and Tips to Use Them," he also highlighted the DK Score® coronary scoring balloon, clearly stating that its cutting performance is comparable to traditional cutting balloons (cutting balloon), offering an excellent device option for interventional treatments of complex lesions such as CTO.

Image


EuroACTOS 2025

DKmedtech

EuroACTOS 2025 —— This highly anticipated international conference in the field of cardiac intervention concluded successfully at the World Trade Center Rotterdam, Netherlands, from September 11 to 12, 2025. As a result of the strong collaboration between Euro CTO Meeting and ACTOS Meeting, the conference focused precisely on the cutting-edge breakthroughs in revascularization treatment for Chronic Total Occlusion (CTO), attracting hundreds of experts, clinicians, and industry leaders in cardiology from around the globe. During the event, live expert surgical demonstrations vividly showcased treatment approaches for complex CTO cases, while sharing of advanced clinical case studies sparked innovative ideas, establishing an effective platform to promote academic exchange and clinical practice innovation in the global interventional cardiology field.

Image
Image


As a company making its debut at EuroACTOS, we are showcasing our core innovative product —— DK Score® Pro Coronary Scoring Balloon —— with a significant presence., quickly becoming the focal point of the event. At our booth, we not only provided professional visitors with an intuitive understanding of our product advantages through physical displays but also conducted live demonstrations of our patented nickel-titanium winding spring technology. This technology’s remarkable performance in enhancing the precision and safety of balloon dilation received unanimous recognition from attending experts and clients. Numerous visitors stopped to inquire, engaging in in-depth discussions about clinical application scenarios and potential collaborations. This debut at EuroACTOS not only successfully introduced our DK Score® Pro coronary scoring balloon and core patented technology to the heart of Europe's interventional cardiology community, effectively enhancing our brand's professional recognition and influence in the international market, but also, through face-to-face in-depth exchanges, laid a solid foundation for future technical collaboration and deepened clinical cooperation with European partners.

Image


CIRSE 2025

DKmedtech

CIRSE 2025 (Annual Meeting of the Cardiovascular and Interventional Radiological Society of Europe) Grandly Opens at the International Barcelona Convention Center in Barcelona, Spain, from September 13 to 17, 2025. As the top academic and industry event in the global interventional radiology field, this year's conference gathers thousands of radiologists, interventional therapy experts, and industry elites from around the world. Participants engage in in-depth exchanges on cutting-edge breakthroughs, clinical translation, and practical applications of interventional technologies, with vibrant intellectual exchanges taking place on-site.

Image


DK Medtech Sets Up a Special Booth at the Exhibition, Becoming the Focus with a Full Range of Peripheral Vascular Balloon Dilation Catheter Solutions — From the DKaptain® High-Pressure Balloon to the DKutting® High-Pressure Scoring Balloon and the DKuting® LL Peripheral Scoring Balloon., a variety of core products were showcased together, attracting a large number of attending doctors to stop and inquire with their innovative technology and clinical value. At the same time, it also garnered significant attention from professional channel partners. Through face-to-face technical explanations and demand alignment, the booth not only gained widespread recognition but also successfully reached multiple cooperation intentions, paving the way for subsequent collaboration. The participation in CIRSE 2025 allowed DK Medtech's peripheral vascular solutions to further reach the global core market, significantly enhancing the brand's recognition and influence in the international interventional radiology field. This lays a solid foundation for deepening cooperation with European and global partners and expanding the international business landscape in the future.

Image



DK Medtech



Since its establishment in 2015, DK Medtech has always adhered to innovation-driven development and has now become a leading Chinese enterprise in the full range of interventional balloon innovations. It has developed more than ten types of balloons, including standard balloons, high-pressure balloons, scoring balloons, and drug-coated scoring balloons. Its product line covers the needs of almost all vascular intervention fields, such as cardiovascular intervention, peripheral intervention, and neurointervention. Multiple products have received international certifications such as EU CE MDR and US FDA. The company’s self-developed directional scoring technology is utilized in coronary scoring balloons, peripheral scoring balloons, and drug-coated scoring balloons. According to published pre-market RCT studies, its clinical performance shows significantly better clinical benefits compared to imported control groups, achieving excellent results and market position in niche markets.


Image